150 related articles for article (PubMed ID: 38391733)
1. Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments.
Kavakbasi E; Bauermeister H; Lemcke L; Baune BT
Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391733
[TBL] [Abstract][Full Text] [Related]
2. Combination of Acute and Maintenance Esketamine Treatment With Adjunctive Long-Term Vagus Nerve Stimulation in Difficult-to-Treat Depression.
Kavakbasi E; Baune BT
Neuromodulation; 2024 Jun; 27(4):766-773. PubMed ID: 38340111
[TBL] [Abstract][Full Text] [Related]
3. Vagus nerve stimulation as adjunctive therapy in patients with difficult-to-treat depression (RESTORE-LIFE): study protocol design and rationale of a real-world post-market study.
Young AH; Juruena MF; De Zwaef R; Demyttenaere K
BMC Psychiatry; 2020 Sep; 20(1):471. PubMed ID: 32993573
[TBL] [Abstract][Full Text] [Related]
4. Vagus nerve stimulation allows to cease maintenance electroconvulsive therapy in treatment-resistant depression: a retrospective monocentric case series.
Aboubakr O; Domenech P; Heurtebise I; Gaillard R; Guy-Rubin A; Carron R; Duriez P; Gorwood P; Vinckier F; Pallud J; Zanello M
Front Psychiatry; 2023; 14():1305603. PubMed ID: 38352166
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation.
Demyttenaere K; Costa T; Kavakbasi E; Jiang M; Scheltens A; Dibué M; Hall BE; Andrade P; McAllister-Williams RH; Baune BT; Young AH
J Affect Disord; 2024 Jan; 344():284-291. PubMed ID: 37838271
[TBL] [Abstract][Full Text] [Related]
6. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
Aaronson ST; Sears P; Ruvuna F; Bunker M; Conway CR; Dougherty DD; Reimherr FW; Schwartz TL; Zajecka JM
Am J Psychiatry; 2017 Jul; 174(7):640-648. PubMed ID: 28359201
[TBL] [Abstract][Full Text] [Related]
7. The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry.
McAllister-Williams RH; Sousa S; Kumar A; Greco T; Bunker MT; Aaronson ST; Conway CR; Rush AJ
Int J Bipolar Disord; 2020 May; 8(1):13. PubMed ID: 32358769
[TBL] [Abstract][Full Text] [Related]
8. Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy: A Series of 10 Cases.
Aaronson ST; Goldwaser EL; Kutzer DJ; McAllister-Williams RH; Sackeim HA; Rush AJ
J ECT; 2021 Jun; 37(2):84-87. PubMed ID: 34029305
[TBL] [Abstract][Full Text] [Related]
9. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis.
Warnell RL; Elahi N
J ECT; 2007 Jun; 23(2):114-9. PubMed ID: 17548984
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Immunomodulatory Impact of VNS on Peripheral Cytokine Profiles and Its Relationship with Clinical Response in Difficult-to-Treat Depression (DTD).
Kavakbasi E; Van Assche E; Schwarte K; Hohoff C; Baune BT
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673781
[TBL] [Abstract][Full Text] [Related]
11. Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat Depression.
Kraus C; Quach D; Sholtes DM; Kavakbasi E; De Zwaef R; Dibué M; Zajecka J; Baune BT
Neuromodulation; 2022 Apr; 25(3):316-326. PubMed ID: 35123881
[TBL] [Abstract][Full Text] [Related]
12. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression.
Berry SM; Broglio K; Bunker M; Jayewardene A; Olin B; Rush AJ
Med Devices (Auckl); 2013; 6():17-35. PubMed ID: 23482508
[TBL] [Abstract][Full Text] [Related]
13. Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression.
Kumar A; Bunker MT; Aaronson ST; Conway CR; Rothschild AJ; Mordenti G; Rush AJ
Neuropsychiatr Dis Treat; 2019; 15():457-468. PubMed ID: 30858703
[TBL] [Abstract][Full Text] [Related]
14. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
[TBL] [Abstract][Full Text] [Related]
15. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Burke MJ; Husain MM
J ECT; 2006 Sep; 22(3):218-22. PubMed ID: 16957540
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation for focal seizures.
Panebianco M; Rigby A; Marson AG
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD002896. PubMed ID: 35833911
[TBL] [Abstract][Full Text] [Related]
17. Vagus Nerve Stimulation as an Alternative to Maintenance Electroconvulsive Therapy for Difficult-to-Treat Depression.
Migchels C; Obbels J; McAllister-Williams H; Demyttenaere K; Sienaert P
J ECT; 2024 Feb; ():. PubMed ID: 38373170
[TBL] [Abstract][Full Text] [Related]
18. The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders.
Sackeim HA; Dibué M; Bunker MT; Rush AJ
Neuropsychiatr Dis Treat; 2020; 16():3081-3093. PubMed ID: 33364761
[TBL] [Abstract][Full Text] [Related]
19. A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment.
Conway CR; Olin B; Aaronson ST; Sackeim HA; Bunker M; Kriedt C; Greco T; Broglio K; Vestrucci M; Rush AJ
Contemp Clin Trials; 2020 Aug; 95():106066. PubMed ID: 32569757
[TBL] [Abstract][Full Text] [Related]
20. Vagus nerve stimulation for partial seizures.
Panebianco M; Rigby A; Weston J; Marson AG
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD002896. PubMed ID: 25835947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
